Ryan H. Moy, Md, Phd

This study is testing whether two oral drugs, avutometinib and defactinib, can help people with a specific, hard-to-treat type of advanced stomach cancer live longer without their cancer getting worse. The trial is for adults whose cancer has spread or cannot be removed by surger…